Defence Therapeutics (DTCFF) Stock Chart & Stock Price History $0.57 +0.03 (+5.56%) As of 08/29/2025 01:19 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesBuy This Stock Defence Therapeutics Stock Price Performance The Defence Therapeutics (DTCFF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 21.72%, with a year-to-date return of 46.12%. In the past month, the stock has increased 10.34%, reflecting recent market activity. As of the latest close, Defence Therapeutics traded at $0.57 with a market cap of and volume of 25,000 shares. Receive DTCFF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Defence Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+5.56%1 Month PerformanceN/A3 Month Performance+4.55%Year-To-Date Performance+46.12%1 Year Performance+21.72% DTCFF Stock Chart for Tuesday, September, 2, 2025 DTCFF Chart by TradingView Defence Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/01/2025$0.57$0.57$0.59$0.5525,000 shs$0.0008/29/2025$0.54$0.57+5.56%$0.59$0.5525,000 shs$0.0008/28/2025$0.53$0.54+1.91%$0.54$0.5211,200 shs$0.0008/26/2025$0.53$0.53$0.53$0.536,000 shs$0.0008/25/2025$0.45$0.53+18.86%$0.53$0.536,000 shs$0.0008/15/2025$0.45$0.45$0.45$0.45100 shs$0.0008/14/2025$0.47$0.45-5.41%$0.45$0.45100 shs$0.0008/08/2025$0.47$0.47$0.47$0.47100 shs$0.0008/07/2025$0.52$0.47-8.77%$0.47$0.47100 shs$0.00 Related Companies 180 Life Sciences Stock Price Chart 3SBio Stock Price Chart 60 Degrees Pharmaceuticals Stock Price Chart Abcam Stock Price Chart Agentix Stock Price Chart AIM ImmunoTech Stock Price Chart Algernon Pharmaceuticals Stock Price Chart ALK-Abelló A/S Stock Price Chart Alpha Tau Medical Stock Price Chart Apollomics Stock Price Chart Receive DTCFF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Defence Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:DTCFF) was last updated on 9/2/2025 by MarketBeat.com Staff From Our PartnersThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSell this, buy thatI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredHave You Seen This? Trump Schedules 'Stock Market Reset' For Sept. 30Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Defence Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Defence Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DTCFF Stock Alerts